New platform identifies best viral vectors for gene therapy
Researchers have developed a novel computational platform that identifies the best viral vector to deliver a gene therapy to its target. The technology, described October 19 in eLife, promises to speed development of adeno-associated virus-mediated gene therapies against vision loss and other disorders. Read More
PerkinElmer, Honeycomb launch single-cell isolation and analysis tool
PerkinElmer and Honeycomb Biotechnologies have launched a new single-cell isolation and analysis tool called Hive scRNAseq. Read More
IsoPlexis raises $125M in IPO
IsoPlexis completed an initial public offering (IPO) on October 12, closing with $125 million on the sale of approximately 8.3 million shares at $15 per share. Read More
Scientists create atlas of mouse brain regions down to single cells
An atlas of the mouse cerebrum and primary motor cortex down to the level of single cells was published in a pair of papers on October 6 in Nature. The research reveals the mammalian brain's organization at an unprecedented level of detail and sheds new light on gene regulatory factors, promising to inform future work on developing targeted therapies for human diseases. Read More
Nanoscale sequencer detects 2 cancer-linked RNA base modifications simultaneously
Using a new nanoscale sequencer, a research group has sequenced a microRNA that is a marker for refractory gastrointestinal cancer. The novel method can detect two types of chemical base modifications simultaneously, according to a study published on September 29 in Scientific Reports. Read More
NanoCellect raises $35M for new development
NanoCellect Biomedical has raised $35 million this year in funding rounds to accelerate the company's commercial growth plans and new product development goals. Read More
Deepcell and Stanford to provide data for new cell atlas project
Deepcell, a life science company that develops artificial intelligence-powered cell classification technology, and Stanford University have entered an agreement to provide data for a new cell atlas project. Read More
Mission Bio updates platform to expand heme-onc research
Mission Bio has improved its Tapestri platform to expand its accessibility and utility in hematologic oncology (heme-onc) research. Read More
INanoBio creates new device to speed up DNA sequencing
Startup INanoBio has developed a new field effect nanopore transistor device, which represents a step toward faster DNA sequencing. Read More
How challenging risky ideas fuels the research ecosystem
If you knew that an experiment would fail, would it be worthwhile to conduct if it had the potential to challenge fundamental hypotheses about science? In a recent interview with ScienceBoard.net, world-renowned Stanford University scientist and serial entrepreneur Stephen Quake, PhD, discussed the value of basic research and his contributions to the biomedical field. Read More
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter